FTV
Fortive Corp
Company overview
- Market capitalization
- $16.84B
- Employees
- 10,000
- Latest publication
- 2026-09-29
About Fortive Corp
Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
Financial statements
Income Quarterly
| Metric | Q2 20262026-07-03 · USD | Q1 20262026-03-31 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,096,800,000USD | 1,069,400,000USD | 1,518,800,000USD | 1,474,200,000USD | 1,620,300,000USD | 1,534,600,000USD | 1,552,400,000USD | 1,524,500,000USD |
| Cost Of Revenue | 401,500,000USD | 393,900,000USD | 623,100,000USD | 593,300,000USD | 643,100,000USD | 613,300,000USD | 624,100,000USD | 620,300,000USD |
| Gross Profit | 695,300,000USD | 675,500,000USD | 895,700,000USD | 880,900,000USD | 977,200,000USD | 921,300,000USD | 928,300,000USD | 904,200,000USD |
| Research Development | 67,500,000USD | 66,500,000USD | 109,200,000USD | 105,100,000USD | 107,100,000USD | 101,700,000USD | 101,100,000USD | 104,100,000USD |
| Selling General Administrative | 417,900,000USD | 417,300,000USD | 564,300,000USD | 542,200,000USD | 563,000,000USD | 524,100,000USD | 525,400,000USD | 561,000,000USD |
| Total Operating Expenses | -485,400,000USD | 483,800,000USD | 632,500,000USD | 620,300,000USD | 666,200,000USD | 623,900,000USD | 626,500,000USD | 665,100,000USD |
| Operating Income | 209,900,000USD | 191,700,000USD | 263,200,000USD | 260,600,000USD | 311,000,000USD | 297,400,000USD | 301,800,000USD | 239,100,000USD |
| Total Other Income Expense Net | -30,400,000USD | -28,100,000USD | -71,200,000USD | -59,200,000USD | -36,300,000USD | -65,200,000USD | -73,100,000USD | -5,100,000USD |
| Interest Expense | 35,400,000USD | 31,600,000USD | 32,100,000USD | 32,000,000USD | 33,100,000USD | 37,000,000USD | 38,700,000USD | 44,000,000USD |
| Income Before Tax | 179,500,000USD | 163,600,000USD | 192,000,000USD | 201,400,000USD | 274,700,000USD | 232,200,000USD | 228,700,000USD | 234,000,000USD |
| Income Tax Expense | 22,200,000USD | 27,200,000USD | 25,400,000USD | 29,500,000USD | 65,900,000USD | 10,600,000USD | 33,600,000USD | 26,600,000USD |
| Discontinued Operations | 0USD | — | — | — | — | — | — | — |
| Net Income | 157,300,000USD | 136,400,000USD | 166,600,000USD | 171,900,000USD | 208,800,000USD | 221,600,000USD | 195,100,000USD | 207,400,000USD |
| Net Interest Income | — | -31,600,000USD | -32,100,000USD | -32,000,000USD | -33,100,000USD | -37,000,000USD | -38,700,000USD | -44,000,000USD |
| Tax Provision | — | 27,200,000USD | 25,400,000USD | 29,500,000USD | 65,900,000USD | 10,600,000USD | 33,600,000USD | 26,600,000USD |
| Net Income From Continuing Ops | — | 136,400,000USD | 166,600,000USD | 171,900,000USD | 208,800,000USD | 221,600,000USD | 195,100,000USD | 207,400,000USD |
| Ebit | — | 195,200,000USD | 224,100,000USD | 233,400,000USD | 307,800,000USD | 269,200,000USD | 267,400,000USD | 278,000,000USD |
| Ebitda | — | 308,800,000USD | 361,600,000USD | 368,300,000USD | 442,600,000USD | 405,000,000USD | 403,900,000USD | 414,800,000USD |
| Depreciation And Amortization | — | 113,600,000USD | 137,500,000USD | 134,900,000USD | 134,800,000USD | 135,800,000USD | 136,500,000USD | 136,800,000USD |
| Reconciled Depreciation | — | 113,600,000USD | 137,800,000USD | 134,900,000USD | 134,800,000USD | 135,800,000USD | 136,500,000USD | 136,800,000USD |
| Unclassified Operating Expenses | — | — | -41,000,000USD | -27,000,000USD | — | — | — | — |
| Interest Income | — | — | 32,100,000USD | 32,000,000USD | 33,100,000USD | 63,100,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | 166,600,000USD | 171,900,000USD | 208,800,000USD | 221,600,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20172017-12-31 · USD | FY 20142014-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6,231,800,000USD | 6,065,300,000USD | 5,825,700,000USD | 5,254,700,000USD | 4,634,400,000USD | 4,563,900,000USD | 5,756,100,000USD | 6,337,200,000USD |
| Cost Of Revenue | 2,500,800,000USD | 2,472,400,000USD | 2,462,300,000USD | 2,244,800,000USD | 2,017,700,000USD | 2,066,900,000USD | 2,832,700,000USD | 3,282,200,000USD |
| Gross Profit | 3,731,000,000USD | 3,594,100,000USD | 3,363,400,000USD | 3,009,900,000USD | 2,616,700,000USD | 2,497,000,000USD | 2,923,400,000USD | 3,055,000,000USD |
| Research Development | 414,000,000USD | 397,800,000USD | 401,500,000USD | 354,800,000USD | 320,700,000USD | 320,300,000USD | 369,300,000USD | 387,600,000USD |
| Selling General Administrative | 2,173,500,000USD | 2,025,000,000USD | 1,956,600,000USD | 1,839,500,000USD | 1,748,000,000USD | 2,219,500,000USD | 1,537,600,000USD | 1,781,700,000USD |
| Unclassified Operating Expenses | -33,200,000USD | 37,600,000USD | — | — | -102,200,000USD | -572,100,000USD | -145,100,000USD | -387,600,000USD |
| Total Operating Expenses | 2,554,300,000USD | 2,460,400,000USD | 2,358,100,000USD | 2,178,400,000USD | 1,966,500,000USD | 1,967,700,000USD | 1,761,800,000USD | 1,781,700,000USD |
| Operating Income | 1,176,700,000USD | 1,133,700,000USD | 1,005,300,000USD | 831,500,000USD | 650,200,000USD | 529,299,999USD | 1,161,600,000USD | 1,273,300,000USD |
| Interest Income | 192,200,000USD | 123,500,000USD | 98,300,000USD | 103,200,000USD | 970,700,000USD | 164,200,000USD | 88,700,000USD | — |
| Interest Expense | 152,800,000USD | 123,500,000USD | 98,300,000USD | 103,200,000USD | 148,500,000USD | 142,600,000USD | 88,700,000USD | 0USD |
| Net Interest Income | -152,800,000USD | -127,100,000USD | -98,300,000USD | -103,200,000USD | -148,500,000USD | -164,200,000USD | -86,000,000USD | — |
| Income Before Tax | 969,600,000USD | 990,800,000USD | 873,500,000USD | 677,500,000USD | 1,507,700,000USD | 336,700,000USD | 1,073,599,999USD | 1,279,200,000USD |
| Income Tax Expense | 136,700,000USD | 125,000,000USD | 118,300,000USD | 63,300,000USD | 55,500,000USD | 68,600,000USD | 189,300,000USD | 395,800,000USD |
| Tax Provision | 136,700,000USD | 142,500,000USD | 118,300,000USD | 63,300,000USD | 55,500,000USD | 149,100,000USD | 259,300,000USD | — |
| Net Income | 832,900,000USD | 865,800,000USD | 755,200,000USD | 608,400,000USD | 1,613,300,000USD | 738,900,000USD | 1,044,500,000USD | 883,400,000USD |
| Net Income From Continuing Ops | 832,900,000USD | 827,800,000USD | 755,200,000USD | 614,200,000USD | 1,452,200,000USD | 725,400,000USD | 1,044,500,000USD | 883,400,000USD |
| Ebit | 1,122,400,000USD | 1,133,700,000USD | 971,800,000USD | 780,700,000USD | 1,656,200,000USD | 479,300,000USD | 1,162,300,000USD | 1,279,200,000USD |
| Ebitda | 1,666,300,000USD | 1,133,700,000USD | 1,437,400,000USD | 1,176,200,000USD | 2,040,200,000USD | 820,800,000USD | 1,320,600,000USD | 1,457,200,000USD |
| Depreciation And Amortization | 543,900,000USD | 456,800,000USD | 465,600,000USD | 395,500,000USD | 384,000,000USD | 341,500,000USD | 158,300,000USD | 178,000,000USD |
| Reconciled Depreciation | 543,900,000USD | 457,700,000USD | 465,600,000USD | 395,500,000USD | 384,000,000USD | 426,200,000USD | 174,100,000USD | — |
| Total Other Income Expense Net | -207,100,000USD | -142,900,000USD | -131,800,000USD | -154,000,000USD | 857,500,000USD | -192,599,999USD | -88,000,000USD | 5,900,000USD |
| Net Income Applicable To Common Shares | 832,900,000USD | 865,800,000USD | 755,200,000USD | 573,900,000USD | 1,544,300,000USD | 669,900,000USD | 1,044,500,000USD | 883,400,000USD |
| Non Operating Income Net Other | — | — | — | -119,000,000USD | -2,400,000USD | -6,200,000USD | -70,700,000USD | — |
| Discontinued Operations | — | — | — | -5,800,000USD | 161,100,000USD | 470,800,000USD | 160,200,000USD | — |
| Minority Interest | — | — | — | — | 8,500,000USD | 13,200,000USD | 17,900,000USD | 3,200,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-07-03 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 11,615,000,000USD | 11,584,100,000USD | 11,737,700,000USD | 11,886,700,000USD | 18,244,200,000USD | 17,137,000,000USD | 17,016,100,000USD | 17,453,600,000USD |
| Cash And Equivalents | 374,200,000USD | — | 375,500,000USD | 430,800,000USD | 1,832,700,000USD | 892,100,000USD | 813,300,000USD | 811,300,000USD |
| Total Current Assets | 1,597,100,000USD | 1,547,200,000USD | 1,605,700,000USD | 1,731,600,000USD | 3,683,400,000USD | 2,704,100,000USD | 2,592,300,000USD | 2,635,200,000USD |
| Other Current Assets | 249,400,000USD | 238,600,000USD | 254,800,000USD | 206,600,000USD | 328,100,000USD | 314,700,000USD | 288,800,000USD | 347,800,000USD |
| Other Non Current Assets | 375,800,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 5,545,600,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 1,286,600,000USD | 2,185,300,000USD | 2,246,600,000USD | 2,469,500,000USD | 3,745,600,000USD | 2,725,700,000USD | 2,238,400,000USD | 2,100,800,000USD |
| Other Current Liabilities | 858,700,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 749,700,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 6,060,600,000USD | 6,083,100,000USD | 6,453,400,000USD | 6,503,900,000USD | 10,382,100,000USD | 10,236,400,000USD | 10,188,600,000USD | 10,554,900,000USD |
| Total Equity Including Noncontrolling Interest | 6,069,400,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 0USD | 899,800,000USD | 899,500,000USD | 1,189,200,000USD | 1,905,700,000USD | 933,800,000USD | 376,200,000USD | 408,100,000USD |
| Long Term Debt | 3,509,300,000USD | 2,589,300,000USD | 2,306,500,000USD | 2,117,100,000USD | 2,906,500,000USD | 2,929,100,000USD | 3,331,100,000USD | 3,451,800,000USD |
| Deferred Revenue | 452,000,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 24,700,000USD | — | — | — | — | — | — | — |
| Net Receivables | 657,800,000USD | 647,000,000USD | 683,600,000USD | 783,600,000USD | 912,200,000USD | 929,300,000USD | 945,400,000USD | 912,200,000USD |
| Inventory | 310,800,000USD | 305,500,000USD | 291,800,000USD | 310,600,000USD | 610,400,000USD | 568,000,000USD | 544,800,000USD | 563,900,000USD |
| Property Plant Equipment Net | 365,500,000USD | 276,300,000USD | 269,800,000USD | 258,700,000USD | 447,900,000USD | 433,900,000USD | 433,100,000USD | 425,100,000USD |
| Goodwill | 7,339,700,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 2,022,100,000USD | 2,093,500,000USD | 2,188,400,000USD | 2,268,400,000USD | 3,199,900,000USD | 3,258,500,000USD | 3,340,000,000USD | 3,510,000,000USD |
| Accounts Payable | 427,900,000USD | 415,900,000USD | 436,400,000USD | 427,600,000USD | 700,500,000USD | 669,300,000USD | 677,400,000USD | 623,800,000USD |
| Common Stock | 3,700,000USD | 3,700,000USD | 3,700,000USD | 3,700,000USD | 3,700,000USD | 3,700,000USD | 3,700,000USD | 3,700,000USD |
| Retained Earnings | 5,685,700,000USD | 5,546,500,000USD | 5,428,500,000USD | 5,264,300,000USD | 8,511,900,000USD | 8,372,300,000USD | 8,227,600,000USD | 8,046,100,000USD |
| Accumulated Other Comprehensive Income | 44,800,000USD | 41,500,000USD | 41,000,000USD | 34,200,000USD | -287,300,000USD | -395,300,000USD | -465,400,000USD | -334,200,000USD |
| Total Liab | — | 5,501,000,000USD | 5,284,300,000USD | 5,382,800,000USD | 7,855,000,000USD | 6,893,700,000USD | 6,820,500,000USD | 6,892,100,000USD |
| Other Current Liab | — | 421,600,000USD | 910,700,000USD | 852,700,000USD | 1,139,400,000USD | 1,122,600,000USD | 449,000,000USD | 1,068,900,000USD |
| Capital Stock | — | 3,700,000USD | 3,700,000USD | 3,700,000USD | 3,700,000USD | 3,700,000USD | 3,700,000USD | 3,700,000USD |
| Good Will | — | 7,288,500,000USD | 7,298,300,000USD | 7,276,200,000USD | 10,403,700,000USD | 10,244,700,000USD | 10,156,000,000USD | 10,322,300,000USD |
| Cash | — | 356,100,000USD | 375,500,000USD | 430,800,000USD | 1,832,700,000USD | 892,100,000USD | 813,300,000USD | 811,300,000USD |
| Cash And Short Term Investments | — | 356,100,000USD | 375,500,000USD | 430,800,000USD | 1,832,700,000USD | 892,100,000USD | 813,300,000USD | 811,300,000USD |
| Current Deferred Revenue | — | 448,000,000USD | — | — | 565,900,000USD | — | 553,200,000USD | 510,800,000USD |
| Net Debt | — | 3,133,000,000USD | 2,830,500,000USD | 2,875,500,000USD | 2,979,500,000USD | 2,970,800,000USD | 3,063,600,000USD | 3,048,600,000USD |
| Short Term Debt | — | 899,800,000USD | 899,500,000USD | 1,189,200,000USD | 1,905,700,000USD | 933,800,000USD | 413,000,000USD | 408,100,000USD |
| Short Long Term Debt Total | — | 3,489,100,000USD | 3,206,000,000USD | 3,306,300,000USD | 4,812,200,000USD | 3,862,900,000USD | 3,876,900,000USD | 3,859,900,000USD |
| Property Plant Equipment Gross | — | 723,300,000USD | 700,000,000USD | 685,200,000USD | 1,305,700,000USD | 1,275,300,000USD | 1,261,700,000USD | 1,241,700,000USD |
| Common Stock Shares Outstanding | — | 312,800,000shares | 319,400,000shares | 333,400,000shares | 341,700,000shares | 344,600,000shares | 348,000,000shares | 352,300,000shares |
| Non Current Assets Total | — | 10,036,900,000USD | 10,132,000,000USD | 10,155,100,000USD | 14,560,800,000USD | 14,432,900,000USD | 14,423,800,000USD | 14,818,400,000USD |
| Non Current Liabilities Total | — | 3,315,700,000USD | 3,037,700,000USD | 2,913,300,000USD | 4,109,400,000USD | 4,168,000,000USD | 4,582,100,000USD | 4,791,300,000USD |
| Non Current Liabilities Other | — | 718,100,000USD | 9,500,000USD | 788,600,000USD | 1,202,900,000USD | 1,238,900,000USD | 12,100,000USD | 1,339,500,000USD |
| Non Currrent Assets Other | — | 378,600,000USD | 375,500,000USD | 272,800,000USD | 437,300,000USD | 495,800,000USD | 494,700,000USD | 561,000,000USD |
| Net Working Capital | — | -638,100,000USD | -640,900,000USD | -737,900,000USD | -62,200,000USD | -21,600,000USD | 353,900,000USD | 534,400,000USD |
| Unclassified Current Liabilities | — | -899,800,000USD | -899,500,000USD | -1,189,200,000USD | -2,471,600,000USD | -933,800,000USD | -230,400,000USD | -918,900,000USD |
| Unclassified Equity | — | 487,700,000USD | 976,500,000USD | 1,198,000,000USD | 2,150,100,000USD | 2,252,000,000USD | 2,419,000,000USD | 2,835,600,000USD |
| Other Assets | — | — | 375,500,000USD | 261,200,000USD | 509,300,000USD | 495,800,000USD | 494,700,000USD | 561,000,000USD |
| Unclassified Non Current Assets | — | — | -375,500,000USD | -182,200,000USD | -437,300,000USD | -495,800,000USD | -494,700,000USD | -561,000,000USD |
| Unclassified Non Current Liabilities | — | — | 721,700,000USD | — | — | — | 1,238,900,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 11,737,700,000USD | 17,016,100,000USD | 16,911,800,000USD | 15,890,600,000USD | 16,465,500,000USD | 16,051,500,000USD | 17,439,000,000USD | 12,905,600,000USD |
| Intangible Assets | 2,188,400,000USD | 3,340,000,000USD | 3,159,800,000USD | 3,487,400,000USD | 3,890,200,000USD | 3,290,600,000USD | 3,845,000,000USD | 2,476,300,000USD |
| Other Current Assets | 254,800,000USD | 288,800,000USD | 285,100,000USD | 272,600,000USD | 252,700,000USD | 237,100,000USD | 1,176,700,000USD | 223,200,000USD |
| Total Liab | 5,276,600,000USD | 6,820,500,000USD | 6,586,500,000USD | 6,202,000,000USD | 6,948,500,000USD | 7,078,800,000USD | 10,038,800,000USD | 6,292,700,000USD |
| Total Stockholder Equity | 6,453,400,000USD | 10,188,600,000USD | 10,318,900,000USD | 9,683,400,000USD | 9,512,200,000USD | 8,964,200,000USD | 7,387,000,000USD | 6,595,500,000USD |
| Other Current Liab | 910,700,000USD | 449,000,000USD | 470,700,000USD | 423,900,000USD | 450,100,000USD | 491,300,000USD | 1,054,100,000USD | 567,200,000USD |
| Common Stock | 3,700,000USD | 3,700,000USD | 3,600,000USD | 3,600,000USD | 3,600,000USD | 3,400,000USD | 3,400,000USD | 3,400,000USD |
| Capital Stock | 3,700,000USD | 3,700,000USD | 3,600,000USD | 3,600,000USD | 3,600,000USD | 3,400,000USD | 3,400,000USD | 3,400,000USD |
| Retained Earnings | 5,428,500,000USD | 8,227,600,000USD | 7,505,900,000USD | 6,742,100,000USD | 6,023,600,000USD | 5,547,400,000USD | 4,128,800,000USD | 3,552,700,000USD |
| Good Will | 7,298,300,000USD | 10,156,000,000USD | 9,121,700,000USD | 9,048,500,000USD | 9,152,000,000USD | 7,359,200,000USD | 8,399,300,000USD | 6,133,100,000USD |
| Other Assets | 375,500,000USD | 494,700,000USD | 1USD | 455,800,000USD | 337,300,000USD | 344,100,000USD | 2,271,000,000USD | 548,900,000USD |
| Cash | 375,500,000USD | 813,300,000USD | 1,888,800,000USD | 709,200,000USD | 819,300,000USD | 1,824,800,000USD | 1,205,200,000USD | 1,178,400,000USD |
| Cash And Equivalents | 375,500,000USD | 813,300,000USD | 1,888,800,000USD | 709,200,000USD | 819,300,000USD | 1,824,800,000USD | 1,205,200,000USD | 1,178,400,000USD |
| Cash And Short Term Investments | 375,500,000USD | 813,300,000USD | 1,888,800,000USD | 709,200,000USD | 819,300,000USD | 2,944,000,000USD | 1,205,200,000USD | 1,178,400,000USD |
| Total Current Assets | 1,605,700,000USD | 2,592,300,000USD | 3,671,600,000USD | 2,477,000,000USD | 2,514,900,000USD | 4,446,900,000USD | 3,688,800,000USD | 3,171,200,000USD |
| Total Current Liabilities | 2,246,600,000USD | 2,238,400,000USD | 1,791,300,000USD | 2,727,100,000USD | 3,714,900,000USD | 2,860,800,000USD | 3,467,200,000USD | 2,192,100,000USD |
| Net Debt | 2,830,500,000USD | 3,063,600,000USD | 1,921,300,000USD | 2,711,500,000USD | 3,324,200,000USD | 2,606,600,000USD | 5,296,900,000USD | 2,251,900,000USD |
| Short Term Debt | 899,500,000USD | 413,000,000USD | 37,600,000USD | 1,038,100,000USD | 2,196,300,000USD | 1,446,800,000USD | 1,542,100,000USD | 455,600,000USD |
| Short Long Term Debt | 899,500,000USD | 376,200,000USD | — | 999,700,000USD | 2,151,700,000USD | 1,399,800,000USD | 1,500,000,000USD | 455,600,000USD |
| Short Long Term Debt Total | 3,206,000,000USD | 3,876,900,000USD | 3,810,100,000USD | 3,420,700,000USD | 4,143,500,000USD | 4,431,400,000USD | 6,502,100,000USD | 3,430,300,000USD |
| Long Term Debt | 2,306,500,000USD | 3,331,100,000USD | 3,646,200,000USD | 2,251,600,000USD | 1,807,300,000USD | 2,830,300,000USD | 4,828,400,000USD | 2,974,700,000USD |
| Net Receivables | 683,600,000USD | 945,400,000USD | 960,800,000USD | 958,500,000USD | 930,200,000USD | 810,300,000USD | 890,700,000USD | 1,195,100,000USD |
| Inventory | 291,800,000USD | 544,800,000USD | 536,900,000USD | 536,700,000USD | 512,700,000USD | 455,500,000USD | 640,300,000USD | 574,500,000USD |
| Accounts Payable | 436,400,000USD | 677,400,000USD | 608,600,000USD | 623,000,000USD | 557,900,000USD | 480,800,000USD | 449,000,000USD | 706,500,000USD |
| Property Plant Equipment Net | 269,800,000USD | 433,100,000USD | 439,800,000USD | 421,900,000USD | 395,500,000USD | 610,700,000USD | 585,000,000USD | 576,100,000USD |
| Property Plant Equipment Gross | 700,000,000USD | 1,261,700,000USD | 1,248,800,000USD | 1,176,400,000USD | 571,100,000USD | 610,700,000USD | 726,300,000USD | 576,100,000USD |
| Accumulated Other Comprehensive Income | 41,000,000USD | -465,400,000USD | -326,100,000USD | -325,700,000USD | -185,000,000USD | -141,100,000USD | -56,300,000USD | -86,600,000USD |
| Common Stock Shares Outstanding | 319,400,000shares | 352,800,000shares | 355,600,000shares | 360,800,000shares | 352,300,000shares | 359,000,000shares | 340,000,000shares | 350,700,000shares |
| Non Current Assets Total | 10,132,000,000USD | 14,423,800,000USD | 13,240,200,000USD | 13,413,600,000USD | 13,950,600,000USD | 11,604,600,000USD | 13,750,200,000USD | 9,734,400,000USD |
| Non Current Liabilities Total | 3,030,000,000USD | 4,582,100,000USD | 4,795,200,000USD | 3,474,900,000USD | 3,233,600,000USD | 4,218,000,000USD | 6,571,600,000USD | 4,100,600,000USD |
| Non Current Liabilities Other | 9,500,000USD | 12,100,000USD | 9,700,000USD | 1,223,300,000USD | 1,286,400,000USD | 1,233,400,000USD | 68,500,000USD | 51,700,000USD |
| Non Currrent Assets Other | 375,500,000USD | 435,700,000USD | 518,900,000USD | 455,800,000USD | 512,900,000USD | 344,100,000USD | 2,353,000,000USD | 548,900,000USD |
| Net Working Capital | -640,900,000USD | 353,900,000USD | 1,880,300,000USD | -250,100,000USD | -1,200,000,000USD | 1,586,100,000USD | 221,600,000USD | 979,100,000USD |
| Unclassified Non Current Assets | -375,500,000USD | -435,700,000USD | — | -455,800,000USD | -337,300,000USD | -344,100,000USD | -3,785,100,000USD | -548,900,000USD |
| Unclassified Current Liabilities | -899,500,000USD | -230,400,000USD | 129,800,000USD | -867,200,000USD | -2,098,700,000USD | -1,334,300,000USD | -1,401,000,000USD | -280,900,000USD |
| Unclassified Non Current Liabilities | 714,000,000USD | 1,238,900,000USD | 1,139,300,000USD | -1,092,300,000USD | -1,146,500,000USD | -1,079,100,000USD | — | -51,700,000USD |
| Unclassified Equity | 976,500,000USD | 2,419,000,000USD | 3,131,900,000USD | 3,259,800,000USD | 3,666,400,000USD | 3,551,100,000USD | 3,307,700,000USD | 3,122,600,000USD |
| Current Deferred Revenue | — | 553,200,000USD | 544,600,000USD | 509,600,000USD | 457,600,000USD | 376,400,000USD | 323,000,000USD | 288,100,000USD |
| Other Liab | — | — | — | 1,092,300,000USD | 1,286,400,000USD | 1,233,400,000USD | 1,611,600,000USD | 1,125,900,000USD |
| Net Tangible Assets | — | — | — | -2,852,500,000USD | -3,530,000,000USD | -1,531,300,000USD | -3,425,200,000USD | -2,013,900,000USD |
| Short Term Investments | — | — | — | — | 0USD | 1,119,200,000USD | 0USD | — |
| Long Term Investments | — | — | — | — | — | — | 82,000,000USD | — |
| Unclassified Current Assets | — | — | — | — | — | — | -224,100,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-07-03 · USD |
|---|---|
| Depreciation | 227,100,000USD |
| Stock Based Compensation | 45,200,000USD |
| Change To Account Receivables | 26,000,000USD |
| Change To Inventory | -20,000,000USD |
| Change To Liabilities | -50,400,000USD |
| Change In Working Capital | -3,900,000USD |
| Operating Cash Flow | 521,000,000USD |
| Capital Expenditures | -54,700,000USD |
| Other Investing Activities | -62,800,000USD |
| Unclassified Investing Cash Flow | 9,400,000USD |
| Investing Cash Flow | -108,100,000USD |
| Net Debt Issuance | 433,600,000USD |
| Net Common Stock Issuance | -700,300,000USD |
| Common Dividends Paid | -18,400,000USD |
| Other Financing Activities | -10,700,000USD |
| Unclassified Financing Cash Flow | -104,400,000USD |
| Financing Cash Flow | -400,200,000USD |
| Effect Of Forex Changes On Cash | 4,100,000USD |
| Change In Cash | 16,800,000USD |
| End Cash Flow | 392,300,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 136,400,000USD | 191,500,000USD | 2,700,000USD | 166,600,000USD | 171,900,000USD | 208,800,000USD | 221,600,000USD | 195,100,000USD |
| Depreciation | 113,600,000USD | 111,300,000USD | 53,600,000USD | 137,800,000USD | 134,900,000USD | 134,800,000USD | 135,800,000USD | 136,500,000USD |
| Stock Based Compensation | 21,300,000USD | 19,900,000USD | 42,000,000USD | 27,400,000USD | 27,500,000USD | 28,200,000USD | 27,900,000USD | 24,200,000USD |
| Other Non Cash Items | 17,600,000USD | 21,700,000USD | 25,800,000USD | -113,200,000USD | -92,600,000USD | -65,000,000USD | 39,400,000USD | 25,600,000USD |
| Change To Account Receivables | -34,800,000USD | -47,500,000USD | -19,300,000USD | 44,100,000USD | 31,400,000USD | -69,100,000USD | 40,000,000USD | 15,800,000USD |
| Change To Inventory | 14,800,000USD | 20,200,000USD | 17,500,000USD | -39,600,000USD | -18,100,000USD | 4,500,000USD | 16,300,000USD | 1,100,000USD |
| Change In Working Capital | -54,100,000USD | 21,500,000USD | 40,300,000USD | -20,600,000USD | -92,600,000USD | 195,400,000USD | 34,300,000USD | -72,500,000USD |
| Total Cash From Operating Activities | 234,800,000USD | 365,900,000USD | 164,400,000USD | 311,200,000USD | 241,700,000USD | 502,200,000USD | 459,000,000USD | 308,900,000USD |
| Capital Expenditures | -26,600,000USD | -30,400,000USD | -11,300,000USD | -36,700,000USD | -26,700,000USD | -22,600,000USD | -27,800,000USD | -29,200,000USD |
| Free Cash Flow | 208,200,000USD | 335,500,000USD | 153,100,000USD | 274,500,000USD | 215,000,000USD | 479,600,000USD | 431,200,000USD | 279,700,000USD |
| Total Cashflows From Investing Activities | -26,700,000USD | -56,200,000USD | -28,400,000USD | -24,600,000USD | -26,200,000USD | 3,800,000USD | -17,600,000USD | -44,800,000USD |
| Net Borrowings | 298,800,000USD | -104,900,000USD | -1,503,500,000USD | 812,900,000USD | 80,700,000USD | -25,300,000USD | 300,000USD | — |
| Total Cash From Financing Activities | -228,500,000USD | -363,500,000USD | -1,532,400,000USD | 650,300,000USD | -141,000,000USD | -496,000,000USD | -281,600,000USD | -322,000,000USD |
| Dividends Paid | -18,400,000USD | -18,800,000USD | -19,200,000USD | -27,000,000USD | -27,200,000USD | -27,300,000USD | -27,800,000USD | -28,000,000USD |
| Sale Purchase Of Stock | -500,200,000USD | -265,000,000USD | -344,500,000USD | -141,900,000USD | -202,600,000USD | -466,600,000USD | -270,100,000USD | -152,900,000USD |
| Change In Cash | -19,400,000USD | -55,300,000USD | -1,401,900,000USD | 940,600,000USD | 78,800,000USD | 2,000,000USD | 167,200,000USD | -60,500,000USD |
| Begin Period Cash Flow | 375,500,000USD | 430,800,000USD | 1,832,700,000USD | 892,100,000USD | 813,300,000USD | 811,300,000USD | 644,100,000USD | 704,600,000USD |
| End Period Cash Flow | 356,100,000USD | 375,500,000USD | 430,800,000USD | 1,832,700,000USD | 892,100,000USD | 813,300,000USD | 811,300,000USD | 644,100,000USD |
| Other Cashflows From Investing Activities | -100,000USD | -100,000USD | -15,800,000USD | 12,100,000USD | 500,000USD | 27,100,000USD | 7,000,000USD | -1,600,000USD |
| Other Cashflows From Financing Activities | -8,700,000USD | 25,200,000USD | 334,800,000USD | 6,300,000USD | 8,100,000USD | 23,200,000USD | 16,000,000USD | 6,500,000USD |
| Unclassified Investing Cash Flow | — | -25,700,000USD | 27,100,000USD | 24,600,000USD | 26,200,000USD | -4,500,000USD | 20,800,000USD | 30,800,000USD |
| Investments | — | — | -28,400,000USD | -24,600,000USD | -26,200,000USD | 3,800,000USD | -17,600,000USD | -44,800,000USD |
| Unclassified Operating Cash Flow | — | — | — | 113,200,000USD | 92,600,000USD | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | — | -147,600,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 579,200,000USD | 832,900,000USD | 865,800,000USD | 755,200,000USD | 614,200,000USD | 918,300,000USD | 1,044,500,000USD | 872,300,000USD |
| Depreciation | 437,600,000USD | 543,900,000USD | 456,800,000USD | 465,600,000USD | 395,500,000USD | 260,800,000USD | 174,100,000USD | 176,400,000USD |
| Stock Based Compensation | 116,800,000USD | 109,200,000USD | 113,300,000USD | 93,800,000USD | 77,400,000USD | 50,800,000USD | 48,600,000USD | 45,300,000USD |
| Other Non Cash Items | 399,400,000USD | 1,900,000USD | 1,035,600,000USD | 71,300,000USD | -29,900,000USD | 136,500,000USD | 57,200,000USD | 14,800,000USD |
| Change To Account Receivables | 8,700,000USD | -4,500,000USD | 9,800,000USD | -52,100,000USD | -84,100,000USD | -105,900,000USD | -65,400,000USD | 24,800,000USD |
| Change To Inventory | -20,000,000USD | 8,800,000USD | -1,700,000USD | -40,300,000USD | -53,600,000USD | -73,400,000USD | 14,300,000USD | -28,700,000USD |
| Change In Working Capital | -399,900,000USD | 103,900,000USD | 21,800,000USD | -20,600,000USD | -111,500,000USD | -29,700,000USD | -69,800,000USD | 38,100,000USD |
| Total Cash From Operating Activities | 1,083,200,000USD | 1,526,800,000USD | 1,353,600,000USD | 1,303,200,000USD | 961,100,000USD | 1,344,400,000USD | 1,176,400,000USD | 1,136,900,000USD |
| Capital Expenditures | -105,100,000USD | -120,400,000USD | -107,800,000USD | -95,800,000USD | -50,000,000USD | -112,300,000USD | -136,100,000USD | -129,600,000USD |
| Free Cash Flow | 978,100,000USD | 1,406,400,000USD | 1,245,800,000USD | 1,207,400,000USD | 911,100,000USD | 1,232,100,000USD | 1,040,300,000USD | 1,007,300,000USD |
| Total Cashflows From Investing Activities | -135,400,000USD | -1,796,000,000USD | -195,400,000USD | -102,500,000USD | -2,615,600,000USD | -1,966,600,000USD | -1,669,700,000USD | -310,800,000USD |
| Net Borrowings | -714,800,000USD | 137,000,000USD | 389,200,000USD | -723,900,000USD | 753,600,000USD | -366,100,000USD | 682,100,000USD | 3,351,900,000USD |
| Total Cash From Financing Activities | -1,386,600,000USD | -792,700,000USD | 32,300,000USD | -1,273,000,000USD | 652,000,000USD | 879,100,000USD | 599,700,000USD | 3,800,000USD |
| Dividends Paid | -92,200,000USD | -111,200,000USD | -102,000,000USD | -99,500,000USD | -132,200,000USD | -131,500,000USD | -97,200,000USD | -3,048,400,000USD |
| Sale Purchase Of Stock | -1,610,100,000USD | -889,600,000USD | -272,900,000USD | -442,900,000USD | 0USD | 1,483,900,000USD | 0USD | 0USD |
| Change In Cash | -437,800,000USD | -1,075,500,000USD | 1,179,600,000USD | -110,100,000USD | -1,005,500,000USD | 216,300,000USD | 158,900,000USD | 803,200,000USD |
| Begin Period Cash Flow | 813,300,000USD | 1,888,800,000USD | 709,200,000USD | 819,300,000USD | 1,824,800,000USD | 962,100,000USD | 803,200,000USD | — |
| End Period Cash Flow | 375,500,000USD | 813,300,000USD | 1,888,800,000USD | 709,200,000USD | 819,300,000USD | 1,178,400,000USD | 962,100,000USD | 803,200,000USD |
| Other Cashflows From Investing Activities | -4,600,000USD | 46,200,000USD | 8,200,000USD | -6,700,000USD | -2,565,600,000USD | 960,800,000USD | 23,000,000USD | 8,900,000USD |
| Other Cashflows From Financing Activities | 1,030,500,000USD | 71,100,000USD | 18,000,000USD | 1,425,900,000USD | 1,395,300,000USD | 2,456,700,000USD | 14,800,000USD | -299,700,000USD |
| Unclassified Operating Cash Flow | -49,900,000USD | -65,000,000USD | -1,139,700,000USD | -62,100,000USD | 15,400,000USD | — | -78,200,000USD | — |
| Unclassified Investing Cash Flow | -25,700,000USD | 74,200,000USD | 62,600,000USD | 102,500,000USD | 2,615,600,000USD | -848,500,000USD | 113,100,000USD | 120,700,000USD |
| Investments | — | -1,796,000,000USD | -158,400,000USD | -102,500,000USD | -2,615,600,000USD | -1,966,600,000USD | -1,669,700,000USD | -310,800,000USD |
| Change To Liabilities | — | — | — | 19,200,000USD | 32,400,000USD | 78,600,000USD | -43,300,000USD | -3,000,000USD |
| Unclassified Financing Cash Flow | — | — | — | -1,432,600,000USD | -1,364,700,000USD | -2,563,900,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | — | -1,002,500,000USD | 216,300,000USD | 158,900,000USD | 803,200,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | 1,337,400,000USD | — | — |
| Exchange Rate Changes | — | — | — | — | — | -40,600,000USD | 52,500,000USD | -26,700,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-07-03 | Geography | Asia Pacific | 190,100,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-07-03 | Geography | EMEA | 181,300,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-07-03 | Geography | Latin America | 64,900,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-07-03 | Geography | North America | 660,500,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-07-03 | Product | Product | 876,800,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-07-03 | Product | Services | 220,000,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-07-03 | Segment | Advanced Healthcare Solutions | 338,600,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-07-03 | Segment | Corporate And Other | 0 | USD | Disclosure |
| Q2 2026Quarterly · 2026-07-03 | Segment | Intelligent Operating Solutions | 758,200,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Asia Pacific | 194,700,000 | USD | 0001659166-26-000013 |
| Q1 2026Quarterly · 2026-03-31 | Geography | EMEA | 191,800,000 | USD | 0001659166-26-000013 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Latin America | 48,400,000 | USD | 0001659166-26-000013 |
| Q1 2026Quarterly · 2026-03-31 | Geography | North America | 634,500,000 | USD | 0001659166-26-000013 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 860,800,000 | USD | 0001659166-26-000013 |
| Q1 2026Quarterly · 2026-03-31 | Product | Services | 208,600,000 | USD | 0001659166-26-000013 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Advanced Healthcare Solutions | 326,200,000 | USD | 0001659166-26-000013 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Corporate And Other | 0 | USD | 0001659166-26-000013 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Intelligent Operating Solutions | 743,200,000 | USD | 0001659166-26-000013 |
| Q4 2025Quarterly · 2025-12-31 | Product | Product | 444,800,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Services | 175,300,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Asia Pacific | 730,100,000 | USD | 0001659166-26-000007 |
| FY 2025Yearly · 2025-12-31 | Geography | EMEA | 725,800,000 | USD | 0001659166-26-000007 |
| FY 2025Yearly · 2025-12-31 | Geography | Latin America | 212,100,000 | USD | 0001659166-26-000007 |
| FY 2025Yearly · 2025-12-31 | Geography | North America | 2,491,100,000 | USD | 0001659166-26-000007 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 3,341,300,000 | USD | 0001659166-26-000007 |
| FY 2025Yearly · 2025-12-31 | Product | Services | 817,800,000 | USD | 0001659166-26-000007 |
| FY 2025Yearly · 2025-12-31 | Segment | Advanced Healthcare Solutions | 1,302,800,000 | USD | 0001659166-26-000007 |
| FY 2025Yearly · 2025-12-31 | Segment | Corporate And Other | 0 | USD | 0001659166-26-000007 |
| FY 2025Yearly · 2025-12-31 | Segment | Intelligent Operating Solutions | 2,856,300,000 | USD | 0001659166-26-000007 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Asia Pacific | 181,400,000 | USD | 0001659166-25-000131 |
| Q3 2025Quarterly · 2025-09-30 | Geography | EMEA | 167,900,000 | USD | 0001659166-25-000131 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Latin America | 53,100,000 | USD | 0001659166-25-000131 |
| Q3 2025Quarterly · 2025-09-30 | Geography | North America | 624,700,000 | USD | 0001659166-25-000131 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 814,400,000 | USD | 0001659166-25-000131 |
| Q3 2025Quarterly · 2025-09-30 | Product | Services | 212,700,000 | USD | 0001659166-25-000131 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Advanced Healthcare Solutions | 328,300,000 | USD | 0001659166-25-000131 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Corporate And Other | 0 | USD | 0001659166-25-000131 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Intelligent Operating Solutions | 698,800,000 | USD | 0001659166-25-000131 |
| Q2 2025Quarterly · 2025-06-30 | Geography | China | 159,700,000 | USD | 0001659166-25-000120 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Countries Excluding United Statesand China | 533,900,000 | USD | 0001659166-25-000120 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 825,200,000 | USD | 0001659166-25-000120 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 1,277,400,000 | USD | 0001659166-25-000120 |
| Q2 2025Quarterly · 2025-06-30 | Product | Services | 241,400,000 | USD | 0001659166-25-000120 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Asia Pacific | 185,200,000 | USD | 0001659166-26-000013 |
| Q1 2025Quarterly · 2025-03-31 | Geography | EMEA | 167,300,000 | USD | 0001659166-26-000013 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Latin America | 45,500,000 | USD | 0001659166-26-000013 |
| Q1 2025Quarterly · 2025-03-31 | Geography | North America | 595,100,000 | USD | 0001659166-26-000013 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 804,700,000 | USD | 0001659166-26-000013 |
| Q1 2025Quarterly · 2025-03-31 | Product | Services | 188,400,000 | USD | 0001659166-26-000013 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Advanced Healthcare Solutions | 302,200,000 | USD | 0001659166-26-000013 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Corporate And Other | 0 | USD | 0001659166-26-000013 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Intelligent Operating Solutions | 690,900,000 | USD | 0001659166-26-000013 |
| Q4 2024Quarterly · 2024-12-31 | Geography | China | 153,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | Countries Excluding United Statesand China | 567,400,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 899,900,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product | 1,871,000,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Services | 280,200,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Asia Pacific | 733,300,000 | USD | 0001659166-26-000007 |
| FY 2024Yearly · 2024-12-31 | Geography | EMEA | 721,100,000 | USD | 0001659166-26-000007 |
| FY 2024Yearly · 2024-12-31 | Geography | Latin America | 209,700,000 | USD | 0001659166-26-000007 |
| FY 2024Yearly · 2024-12-31 | Geography | North America | 2,416,800,000 | USD | 0001659166-26-000007 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 3,290,900,000 | USD | 0001659166-26-000007 |
| FY 2024Yearly · 2024-12-31 | Product | Services | 790,000,000 | USD | 0001659166-26-000007 |
| FY 2024Yearly · 2024-12-31 | Segment | Advanced Healthcare Solutions | 1,287,700,000 | USD | 0001659166-26-000007 |
| FY 2024Yearly · 2024-12-31 | Segment | Corporate And Other | 0 | USD | 0001659166-26-000007 |
| FY 2024Yearly · 2024-12-31 | Segment | Intelligent Operating Solutions | 2,793,200,000 | USD | 0001659166-26-000007 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Asia Pacific | 177,800,000 | USD | 0001659166-25-000131 |
| Q3 2024Quarterly · 2024-09-30 | Geography | EMEA | 168,100,000 | USD | 0001659166-25-000131 |
| Q3 2024Quarterly · 2024-09-30 | Geography | Latin America | 56,100,000 | USD | 0001659166-25-000131 |
| Q3 2024Quarterly · 2024-09-30 | Geography | North America | 601,700,000 | USD | 0001659166-25-000131 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 802,500,000 | USD | 0001659166-25-000131 |
| Q3 2024Quarterly · 2024-09-30 | Product | Services | 201,200,000 | USD | 0001659166-25-000131 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Advanced Healthcare Solutions | 322,400,000 | USD | 0001659166-25-000131 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Corporate And Other | 0 | USD | 0001659166-25-000131 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Intelligent Operating Solutions | 681,300,000 | USD | 0001659166-25-000131 |
| Q2 2024Quarterly · 2024-06-30 | Geography | China | 165,100,000 | USD | 0001659166-25-000120 |
| Q2 2024Quarterly · 2024-06-30 | Geography | Countries Excluding United Statesand China | 547,000,000 | USD | 0001659166-25-000120 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 840,300,000 | USD | 0001659166-25-000120 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Advanced Healthcare Solutions | 323,600,000 | USD | 0001659166-24-000148 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Intelligent Operating Solutions | 677,000,000 | USD | 0001659166-24-000148 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Precision Technologies | 551,800,000 | USD | 0001659166-24-000148 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Advanced Healthcare Solutions | 299,800,000 | USD | 0001659166-24-000108 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Intelligent Operating Solutions | 665,700,000 | USD | 0001659166-24-000108 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Precision Technologies | 559,000,000 | USD | 0001659166-24-000108 |
| Q4 2023Quarterly · 2023-12-31 | Segment | Advanced Healthcare Solutions | 260,800,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Segment | Intelligent Operating Solutions | 682,700,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Segment | Precision Technologies | 640,200,000 | USD | Legacy provider |
| FY 2023Yearly · 2023-12-31 | Geography | Asia Pacific | 727,200,000 | USD | 0001659166-26-000007 |
| FY 2023Yearly · 2023-12-31 | Geography | EMEA | 697,600,000 | USD | 0001659166-26-000007 |
| FY 2023Yearly · 2023-12-31 | Geography | Latin America | 196,700,000 | USD | 0001659166-26-000007 |
| FY 2023Yearly · 2023-12-31 | Geography | North America | 2,292,400,000 | USD | 0001659166-26-000007 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 3,157,700,000 | USD | 0001659166-26-000007 |
| FY 2023Yearly · 2023-12-31 | Product | Services | 756,200,000 | USD | 0001659166-26-000007 |
| FY 2023Yearly · 2023-12-31 | Segment | Advanced Healthcare Solutions | 1,229,400,000 | USD | 0001659166-26-000007 |
| FY 2023Yearly · 2023-12-31 | Segment | Corporate And Other | 0 | USD | 0001659166-26-000007 |
| FY 2023Yearly · 2023-12-31 | Segment | Intelligent Operating Solutions | 2,684,500,000 | USD | 0001659166-26-000007 |
| FY 2022Yearly · 2022-12-31 | Geography | China | 702,100,000 | USD | 0001659166-25-000024 |
| FY 2022Yearly · 2022-12-31 | Geography | Countries Excluding United Statesand China | 1,986,800,000 | USD | 0001659166-25-000024 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 3,136,800,000 | USD | 0001659166-25-000024 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 4,920,100,000 | USD | 0001659166-25-000024 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.